Cardiac disease in renal failure;Patologia cardiaca en el paciente con nefropatia cronica

Revista Espanola de Cardiologia

Volumn 51, Issue 6, 1998, Pages 479-486

  Pérez De Prado, Armando ^a  

^a HOSPITAL DE LEÓN   (Spain)

Author keywords

Cardiac disease; Renal failure

Indexed keywords

ACEBUTOLOL; AMILORIDE; ANTIARRHYTHMIC AGENT; ANTILIPEMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARDIOVASCULAR AGENT; CLOFIBRATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; FOSINOPRIL; ISOSORBIDE DINITRATE; LISINOPRIL; MINOXIDIL; NITROPRUSSIDE SODIUM; PROCAINAMIDE; QUINAPRIL; QUINIDINE; RAMIPRIL; SPIRONOLACTONE; UNINDEXED DRUG; VASODILATOR AGENT; VERAPAMIL;

COMORBIDITY; CREATININE CLEARANCE; DIABETES MELLITUS; DOSE KIDNEY FUNCTION RELATION; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; PERICARDIAL DISEASE; REVIEW; RISK FACTOR; VALVULAR HEART DISEASE; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; MALE;

FEMALE; HEART DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MYOCARDIAL ISCHEMIA; RISK FACTORS;

EID: 7344239368     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(98)74777-3     Document Type: Review

References (69)

1. United States Renal Data System: 1994 Annual Report. Am J Kidney Dis 1994; 24 (Supl 2): 48-56.
2. Churchill DN, Taylor DW, Cook RJ, La Plante P, Barre P, Cartier P et al. Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 1992; 19: 214-234.
3. Leier CV, Boudoulas H. Cardiorenal disorders and diseases. Mount Kisco, NY: Futura Publishing Co., 1992.
4. Ma KW, Greene ET, Raji L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 1992; 19: 505-513.
5. a ed.). Filadelfia: WB Saunders, 1997; 1.914-1.938.
6. Converse RL, Jacobsen TN, Toto RD, Jost CMT, Cosentino F, Fouad-Tarazi F et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1.912-1.918.
7. Koyama H, Tabata T, Nishzawa Y, Inoue T, Morii H, Yamaji T. Plasma endothelin levels in patients with uremia. Lancet 1989; 1: 991-992.
8. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S et al. Plasma endothelin levels in patients with uremia. Hypertension 1990; 15: 493-496.
9. a ed.). Filadelfia: WB Saunders, 1991; 2.019-2.035.
10. Raine AEG, Roger SD. Effects of erythropoieitin in blood pressure. Am J Kidney Dis 1991; 18 (Supl 1): 76-83.
11. Creaves SC, Sharpe DN. Cardiovascular diseases in patients with end-stage renal failure. Aust NZ J Med 1992; 22: 153-159.
12. Barbagallo CM, Avema MR, Sparacino V, Galione A, Caputo F, Scafidi V et al. Lipoprotein levels in end stage renal failure and renal transplantation. Nephron 1993; 64: 560-564.
13. Bergesio F, Monzani G, Ciuti R, Serruto A, Benucci A, Frizzi V et al. Lipids and apolipoproteins change during the progression of chronic renal failure. Clin Nephrol 1992; 81: 264-270.
14. Maggi E, Bellazzi R, Falaschi F, Frattoni A, Perani G, Finardi G et al. Enhanced LDL oxidation in uremic patients. An additional mechanism for accelerated atherosclerosis? Kidney Int 1994; 45: 876-883.
15. Okura Y, Saku K, Hirata K, Zhang B, Liu R, Ogahara S et al. Serum lipoprotein(a) levels in maintenance hemodialysis patients. Nephron 1993; 65: 46-50.
16. Kimura K, Tabei K, Asano Y, Hosoda S. Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors. Nephron 1989; 53: 201-207.
17. Ramirez G, Brueggemeyer CD, Newton JL. Cardiac arrhythmias on hemodialysis in chronic renal failure patients. Nephron 1984; 36: 212-218.
18. Parfrey PS, Harnett JD, Griffiths SM, Taylor R, Hand J, King A et al. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 1990; 55: 114-120.
19. Amann K, Wiest G, Klaus G, Ritz E, Mail G. The role of parathyroid hormone in the genesis of interstitial cell activation in uraemia. J Am Soc Nephrol 1994; 4: 1.814-1.819.
20. Massry SG, Smogorzewski M. Mechanisms through which parathyroid hormone mediates its deleterious effects on organ func tion in uremia. Semin Nephrol 1994; 14: 219-231.
21. Parfrey PS, Harnett JD, Griffiths SM, Gault MH, Barre P. Congestive heart failure in dialysis patients. Arch Intern Med 1988; 148. 1.519-1.525.
22. Rambausek M, Ritz E, Mall G, Mehls O, Katus H. Myocardial hypertrophy in rats with renal insufficiency. Kidney Int 1985; 28: 775-787.
23. Feldman AM, Fionsh B, Zahka KG, Onyang P, Banghman KL. Congestive cardiomyopathy in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1988; 11: 76-79.
24. Lai KN, Barnden L, Mathew TH. Effect of renal transplantation on left ventricular function in hemodialysis patients. Clin Nephrol 1982; 18: 74-78.
25. Bagdade JD, Subbaiah PV, Bartos D, Bartos F, Campbell RA. Polyamines: an unrecognised cardiovascular risk factor in chronic dialysis? Lancet 1979; 1: 412-413.
26. Cohen JL, Barroah B, Segal KR, Batuman V. Two-dimensional echocardiographic findings on hemodialysis for more than six months. Am J Cardiol 1987; 60: 743-745.
27. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC et al. Clinical and echocardiographic cardiovascular disease in end-stage renal disease: prevalence, associations and prognosis. Kidney Int 1995; 47: 186-192.
28. London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F et al. Aortic and large artery compliance in end-stage renal failure. Kidney Int 1990; 37: 137-142.
29. Cannella G, La Canna G, Sandrini M, Gaggiotti M, Nordio G, Movilli E et al. Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. Nephrol Dial Transplant 1991; 6: 31-37.
30. London CM, Marchais SJ, Guerin AP, Metivier F, Pannier B. Cardiac hypertrophy and arterial alterations in end stage renal disease: hemodynamic factors. Kidney Int 1993; 43 (Supl 41): 42-49.
31. Rostand SG, Kirk KA, Rutsky EA. Dialysis-associated ischemic heart disease: insights from coronary angiography. Kidney Int 1984; 25: 653-659.
32. Rostand SG, Brunzell JD, Cannon RD, III, Victor RG. Cardiovascular complications in renal failure. J Am Soc Nephrol 1991; 2: 1.053-1.062.
33. Cardoso M, Vinay P, Vinet B, Lèveillèe M, Prud'homme M, Tejedor A et al. Hypoxemia during hemodialysis: a critical review of the facts. Am J Kidney Dis 1988; 11: 281-297.
34. Wizemann V, Timio M, Alpert MA, Kramer W. Options in dialysis therapy: significance of cardiovascular findings. Kidney Int 1993; 43 (Supl 40): 85-91.
35. Wizemann V, Blank S, Kramer W. Diastolic dysfunction of the left ventricle in dialysis patients. Contrib Nephrol 1994; 106: 106-109.
36. Henrich WL. Effects of dialysis on myocardial contractility. Contr Nephrol 1986; 52: 54-59.
37. Ianhez LE, Lowen J, Sabbaga E. Uremic myocardiopathy. Nephron 1975; 15: 17-28.
38. Burt RK, Gupta-Burt S, Suki WN, Barcenas CG, Ferguson JF, Van Buren CT. Reversal of left ventricular function after renal transplantation. Ann Intern Med 1989; 111: 635-640.
39. Chhabra SC, Sandha GS, Wander GS. Incidence of cardiac arrhythmias in chronic renal failure, especially during hemodialysis. Nephron 1991, 57: 500-501.
40. Kimura K, Tabei K, Hosoda S. Cardiac arrhythmias in hemodialysis patients. Nephron 1989; 53: 201-207
41. Marzegalli M, Bernasconi M, Potenza S, Caprari M, Regalia F, Fiorista F. Incidence, prognosis and therapy of cardiac arrhythmias in dialysis patients. Contrib Nephrol 1988; 61: 181-197.
42. Gonsorcik J, Palko S, Takac M, Mydlik M, Vancik J, Derzsiova K et al. ECG Hoher monitoring in patients with chronic renal failure in a long-term dialysis program. Vnitr-Lek 1992; 38: 258-264.
43. Pérez de Prado A, Verde E, Almendral J, Barambio M, Osende J, Delcán JL. Factores predictores del desarrollo de arritmias supraventriculares durante la hemodiálisis [resumen]. Rev Esp Cardiol 1996; 49 (Supl 3): 107.
44. Pérez de Prado A, Verde E, Almendral J, Barambio M, Osende J, Delcán JL. El rápido aumento de calcio sénco durante la hemodiálisis precipita crisis de fibrilación y flutter auricular [resumen]. Rev Esp Cardiol 1996; 49 (Supl 3): 23.
45. Nishimura M, Nakanishi T, Yasui A, Tsuji Y, Kunishige H, Hirabayashi M et al Serum calcium increases the incidence of arrhythmias during acetate hemodialysis. Am J Kidney Dis 1992; 19. 149-155
46. Rombolá G, Colussi G, Elisabetta M, De Ferrari M, Frontini A, Minetti L. Cardiac arrhythmias and electrolyte changes during haemodialysis. Nephrol Dial Transplant 1992; 7: 318-322.
47. Shapira OM, Bar-Khayim Y. ECG changes and cardiac arrhythmias in chronic renal failure patients on hemodialysis. J Electrocardiol 1992; 25: 273-279.
48. Kremastinos D, Paraskevaidis I, Voudiklari S, Apostolou T, Kyriakides Z, Zirogiannis P et al. Painless myocardial ischemia in chronic hemodialysed patients: a real event? Nephron 1992; 60: 164-170.
49. Adams III JE, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH et al. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 1993; 88: 101-106.
50. Jaffe AS, Ritter C, Meltzer V, Harter H, Roberts R. Unmasking artifactual increases in creatine kinase isoenzymes in patients with renal failure. J Lab Clin Med 1984; 104: 193-202.
51. Cohen IM, Griffiths J, Stone A, Leech T. The creatine kinase profile of a maintenance hemodialysis population: a possible marker of uremic myopathy. Clin Nephrol 1985; 13: 235-238.
52. Singhal PC, Barth RH, Ginsberg NS, Lynn RI. Determinants of serum creatine kinase activity in dialysis patients. Am J Nephrol 1988; 8: 220-224.
53. Holley JL, Fenton RA, Arthur RS. Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med 1991; 90: 563-570.
54. Marwick TH, Steinmuller DR, Underwood DA, Hobbs RE, Go RT, Swift C et al. Ineffectiveness of dipyridamole spect thallium imaging as a screening technique for coronary artery disease in patients with end stage renal failure. Transplantation 1990; 49: 100-103.
55. Brown JH, Vites NP, Testa HJ, Prescott MC, Hunt LP, Gokal R et al. Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure. Nephrol Dial Transplant 1993; 8: 433-437.
56. DePuey EG, Guertler-Krawczynska E, Perkins JV, Robbins WL, Whelchel JD, Clements SD. Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography. Am J Cardiol 1988; 62: 234-238.
57. Kudoh Y, Satoh S, Tsuchida A, Hikita S, Sasa Y, Iimura O. The dual effects of hemodialysis on cardiac function assessed by pulsed Doppler echocardiography. Jpn Circ J 1988; 52: 13-20.
58. Vancheri FS, Barberi O, Rugiano A, Amico C. Non-invasive assessment of changes in left ventricular diastolic time intervals after acute blood volume reduction in haemodialysis. Eur Heart J 1986: 7: 871-876.
59. Sztajzel J, Ruedin P, Monin C, Stoermann C, Leski M, Rutishauser W et al. Effect of altered loading conditions during haemodialysis on left ventricular filling pattern. Eur Heart J 1993; 14: 655-661.
60. Nishimura RA, Abel MD, Hatle LK, Tajik AJ. Relation of pulmonary vein to mitral flow velocities by transesophageal Doppler echocardiography effect of different loading conditions. Circulation 1990; 81: 1.488-1.497.
61. Harnett JD, Murphy B, Collingwood P, Purchase L, Kent G, Parfrey PS. The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients. Nephron 1993; 65: 212-214.
62. Solomon R, Wemer C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1.416-1.420.
63. Maschio G, Alberti D, Janin G, Locatelli F. Mann JFE, Motolese M et al, and the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Group. Effect of angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939-945.
64. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO. Short and long term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990; 119: 484-489.
65. Kellerman PS. Perioperative care of the renal patient. Arch Intern Med 1994; 154: 1.674-1.688.
66. Rutsky EA, Rostand SG. The management of coronary artery disease in patients with end stage renal disease. En: Parfrey PS, Harnett JD, editores. Cardiac dysfunction in chronic uremia. Boston: Kluwer Academic, 1992; 231-246.
67. Batiuk TD, Kurtz SB, Oh JK, Orszulak TA. Coronary artery bypass operation in dialysis patients. Mayo Clin Proc 1991; 66: 45-53.
68. De Meyer M, Wyns W, Khoury G, Pirson Y, Van Ypersele DE, Strihou C. Myocardial revascularization in patients on renal replacement therapy. Clin Nephrol 1991; 36: 147-151.
69. Deutsch E, Bernstein RC, Addonizio VP, Kussmaul III WG. Coronary artery bypass surgery in patients on chronic hemodialysis. Ann Intern Med 1989; 110: 369-372.